Biobanking Market
完整報告名稱與涵蓋範圍
Biobanking Market Size, Share & Trends Analysis Report, By Product and Service (Biobanking Equipment, Consumables, LIMS and Sample Management Software, Biobanking Services), By Sample Type (Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids), By Application, By Region, and Segment Forecasts, 2026-2035
報告摘要
Biobanking encompasses the systematic collection, processing, annotation, storage, and distribution of biological specimens together with the equipment, consumables, informatics, and outsourced services that keep those specimens viable and traceable. The scope of this report spans ultra-low temperature and liquid nitrogen storage systems, automated sample management stores, cryogenic vials and labeling consumables, laboratory information management software, and full-service specimen logistics and repository management.
Momentum comes from the specimen-hungry nature of modern drug development. Cell and gene therapy pipelines require validated cryochains for apheresis material and manufactured doses, while large longitudinal cohort studies and disease-focused registries generate millions of annotated samples that must remain audit-ready for decades. Sponsors are increasingly outsourcing repository management to specialist operators to escape the capital cost of automated minus eighty degree stores and the compliance burden of chain-of-custody documentation. Virtual biobanking models, in which federated catalogs expose specimen inventories across institutions, are reshaping how researchers source rare disease tissue, and sustainability pressure is pushing operators toward higher-density automated freezers with lower energy draw per sample.
North America holds the leading position given the concentration of pharmaceutical sponsors, national cohort programs, and commercial repositories, while Europe benefits from long-established academic biobank networks. Asia Pacific expansion is propelled by government-funded population cohorts in China, Japan, and South Korea. The competitive field is fragmented, mixing global life science tool vendors with cold-chain specialists and service-focused operators.
The InsightAce study provides revenue forecasts in US$ for every product, sample type, application, and regional segment over 2026-2035, alongside segment trend analysis, competitive landscape assessment, and company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biobanking Market Snapshot
Chapter 4. Global Biobanking Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product and Service Estimates & Trend Analysis
5.1. Product and Service & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product and Service:
5.2.1. Biobanking Equipment
5.2.2. Consumables
5.2.3. LIMS and Sample Management Software
5.2.4. Biobanking Services
Chapter 6. Market Segmentation 2: By Sample Type Estimates & Trend Analysis
6.1. Sample Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Sample Type:
6.2.1. Blood Products
6.2.2. Human Tissue
6.2.3. Cell Lines
6.2.4. Nucleic Acids
6.2.5. Biological Fluids
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Drug Discovery and Development
7.2.2. Clinical Research
7.2.3. Regenerative Medicine
7.2.4. Personalized Medicine
Chapter 8. Biobanking Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Thermo Fisher Scientific
10.2. Azenta Life Sciences
10.3. Hamilton Company
10.4. Tecan Group
10.5. QIAGEN
10.6. Merck KGaA
10.7. Becton Dickinson and Company
10.8. Greiner Bio-One
10.9. PHC Holdings
10.10. Eppendorf
10.11. Chart Industries (MVE Biological Solutions)
10.12. BioLifeSolutions
10.13. LabVantage Solutions
10.14. Cryoport
10.15. Precision for Medicine
圖表清單 List of Tables & Figures
Table 1. Global Biobanking Market Revenue Forecast by Product and Service, 2026-2035 (US$ Mn)
Figure 1. Global Biobanking Market Segmentation and Scope Overview
Table 2. Global Biobanking Market Revenue Forecast by Sample Type, 2026-2035 (US$ Mn)
Figure 2. Global Biobanking Market Share by Product and Service, 2026 & 2035
Table 3. Global Biobanking Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Automated Sample Storage Adoption Trend Analysis, 2026-2035
Table 4. North America Biobanking Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 4. Global Biobanking Market Share by Sample Type, 2026 & 2035
Table 5. Europe Biobanking Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Outsourced Repository Services versus In-House Storage Trend Comparison
Table 6. Asia Pacific Biobanking Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Biobanking Growth Opportunity Analysis
Table 7. Latin America Biobanking Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Cell and Gene Therapy Cryochain Demand Outlook
Table 8. Middle East & Africa Biobanking Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Biobanking Participants
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們